In a report released yesterday, Tyler Van Buren from TD Cowen maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a ...

Gilead Sciences: Strong Financial Performance and Promising Outlook Underpin Buy Rating | Markets Insider

The Speculation Around an AstraZeneca-Gilead Merger AstraZeneca, the UK’s largest drugmaker valued at $140bn, has reportedly contacted Gilead Sciences, an American biopharmaceutical company with a market value of approximately $96bn, regarding a possible merger deal.

AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Gilead Sciences, Verizon Communications and ManpowerGroup have rewarded their shareholders for several decades and recently ...

Gilead Sciences, Verizon Communications And ManpowerGroup Are Winners For Passive Income

The latest trading day saw Gilead Sciences (GILD) settling at $83.08, representing a -0.1% change from its previous close.

Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why

NORTHAMPTON, MA / ACCESSWIRE / September 12, 2024 / Each scientific discovery gets us one step closer to our shared goal of ending the HIV epidemic. As a leader in HIV treatment and prevention, we'll continue to build on our legacy and create innovative ...

Helping End HIV - Gilead Sciences

Gilead Sciences, Inc.&#x27;s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or metastatic urothelial cancer fails to achieve its primary endpoint.

Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal

(Reuters) -Gilead Sciences&#x27; Trodelvy failed to improve survival for patients with advanced bladder cancer and only modestly extended the lives of previously treated patients with late-stage lung cancer in a pair of clinical trials, raising questions about growth prospects for the medicine.

Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival

In addition to missing the mark in overall survival, Gilead reported Thursday a higher number of deaths in the Trodelvy arm of the confirmatory metastatic urothelial cancer study.

Gilead’s Trodelvy Fails to Reach Primary Endpoint in Confirmatory Trial | BioSpace

The FDA paused enrollment in the only remaining tests of the drug, as Gilead reviews the program it acquired through a buyout of biotech Forty Seven.

Gilead reviewing drug acquired in $5B buyout after latest setback

Gilead Sciences

A list with 17 of the highest paying cities for Software Engineers in the San Francisco Bay Area. Curate by reports from the verified professionals at Blind.

17 Highest-Paying Cities in the San Francisco Bay Area for Software Engineers

Artificial Intelligence & Deep Learning for Medical Diagnosis

Last December, stories started surfacing of a new virus affecting the Chinese city of Wuhan. At the epicenter of the outbreak, Chinese officials started building new hospitals to aid the people in need. What started out as something that looked like a flu epidemic, soon escalated into a full blown pandemic, called the novel coronavirus (SARS-CoV-2).

4 Potential Drug Treatment Options to Battle This Outbreak of Coronavirus

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and serious cardiovascular and respiratory conditions.

GILEAD SCIENCES

gilead.com

employees

Since 1987

COMPANY RANKING

GILEAD SCIENCES

EVERGREEN INDEX #753

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Gilead Sciences

Gilead Sciences WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

GILEAD SCIENCES

gilead.com

employees

Since 1987

COMPANY RANKING

GILEAD SCIENCES

EVERGREEN INDEX #753

RELATED COMPANIESRANK

HACKERNOON STORIES ON GILEAD SCIENCES

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Gilead Sciences

Gilead Sciences WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!